To analyze the clinical effectiveness of Lianhuaqingwen Granules(LH-C)novel coronavirus pneumonia（NCP）patients.Methods:The clinical data of 54 ordinary NCP patients were retrospectively analyzed at the Puren affiliated Hospital of Wuhan University of Science and Technology.Results:After treatment with LH-C for three consecutive days,the rate of symptoms disappearance in fever,weakness,and cough was 47.5%,35.1%,and 20%,respectively.Five days later,the rate of symptoms disappearance in fever,weakness,and cough increased to 62.5%,59.5%,and 50.0%,respectively.By the seventh day,the rate of symptoms disappearance in fever,weakness,and cough reached 80.0%,75.7%,and 76.7%.The days of symptoms disappearance in fever,weakness,and cough was （3.6±2.14）d,（4.1±2.58）d,and（5.3±2.63）d.As regards the other symptom,the rate of symptoms disappearance in the chest stuffiness,the dyspnea,and the moist crackles was 84.6%,100%,and 89.5%,and the total efficiency was up to 81.6% without any observed side effects by the seventh day.Conclusion:LH-C could significantly relieve clinical symptoms in ordinary NCP patients by inhibiting fever,weakness,and cough,and reducing their duration.All these results provided preliminary clinical evidence for LH-C in the NCP treatment.